Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$28.02 +0.16 (+0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

Acadia Pharmaceuticals (ACAD) Total Debt (QoQ) (2011 - 2012)

Analysis

Acadia Pharmaceuticals (ACAD) Total Debt (QoQ) (2011 - 2012) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Acadia Pharmaceuticals 4.82 Bn 3.86 Bn 279.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2012 -31.25%
Dec 31, 2011 -13.51%
Sep 30, 2011 -7.50%